Cutler Group LP Iovance Biotherapeutics, Inc. Call Options Transaction History

Cutler Group LP

$307 Million
Q1 2024

Call Options

24 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q1 2024 Apr 19, 2024	SELL	$7.59 - $17.47 $120,681 - $277,773	-15,900 Reduced 75.71%	5,100 $1,000
Q4 2023 Jan 18, 2024	BUY	$3.3 - $8.89 $57,750 - $155,575	17,500 Added 500.0%	21,000 $36,000
Q3 2023 Nov 07, 2023	BUY	$4.44 - $8.79 $15,540 - $30,764	3,500 New	3,500 $0
Q4 2022 Feb 07, 2023	SELL	$5.62 - $10.0 $103,408 - $184,000	-18,400 Reduced 81.42%	4,200 $1,000
Q3 2022 Oct 25, 2022	SELL	$9.53 - $13.11 $13,342 - $18,354	-1,400 Reduced 5.83%	22,600 $6,000
Q2 2022 Aug 04, 2022	SELL	$6.38 - $18.33 $366,212 - $1.05 Million	-57,400 Reduced 70.52%	24,000 $33,000
Q1 2022 Apr 14, 2022	BUY	$12.38 - $19.1 $620,238 - $956,910	50,100 Added 160.06%	81,400 $99,000
Q4 2021 Jan 18, 2022	SELL	$16.55 - $27.63 $360,790 - $602,334	-21,800 Reduced 41.05%	31,300 $8,000
Q3 2021 Oct 26, 2021	SELL	$20.35 - $26.63 $392,755 - $513,959	-19,300 Reduced 26.66%	53,100 $41,000
Q2 2021 Jul 19, 2021	BUY	$16.33 - $33.07 $741,381 - $1.5 Million	45,400 Added 168.15%	72,400 $158,000
Q1 2021 Apr 26, 2021	SELL	$28.67 - $52.59 $177,754 - $326,058	-6,200 Reduced 18.67%	27,000 $12,000
Q4 2020 Jan 21, 2021	BUY	$28.04 - $50.26 $815,964 - $1.46 Million	29,100 Added 709.76%	33,200 $163,000
Q3 2020 Oct 27, 2020	SELL	$27.75 - $36.3 $882,450 - $1.15 Million	-31,800 Reduced 88.58%	4,100 $9,000
Q2 2020 Jul 22, 2020	SELL	$27.21 - $41.0 $310,194 - $467,400	-11,400 Reduced 24.1%	35,900 $17,000
Q1 2020 May 07, 2020	BUY	$19.54 - $38.85 $738,612 - $1.47 Million	37,800 Added 397.89%	47,300 $173,000
Q4 2019 Feb 06, 2020	SELL	$17.95 - $29.41 $96,930 - $158,814	-5,400 Reduced 36.24%	9,500 $57,000
Q3 2019 Oct 28, 2019	BUY	$17.99 - $26.0 $178,100 - $257,400	9,900 Added 198.0%	14,900 $6,000
Q2 2019 Aug 09, 2019	BUY	$9.78 - $24.52 $48,900 - $122,600	5,000 New	5,000 $13,000
Q4 2018 Feb 05, 2019	SELL	$7.51 - $11.93 $75,100 - $119,300	-10,000 Closed	0 $0
Q3 2018 Nov 07, 2018	BUY	$11.25 - $17.7 $112,500 - $177,000	10,000 New	10,000 $4,000
Q2 2018 Aug 10, 2018	SELL	$12.45 - $16.95 $176,790 - $240,690	-14,200 Closed	0 $0
Q1 2018 May 11, 2018	SELL	$8.1 - $19.5 $10,530 - $25,350	-1,300 Reduced 8.39%	14,200 $42,000
Q4 2017 Jan 17, 2018	BUY	$6.65 - $9.25 $87,115 - $121,175	13,100 Added 545.83%	15,500 $12,000
Q3 2017 Oct 17, 2017	BUY	$4.45 - $8.55 $10,680 - $20,520	2,400	2,400 $2,000

Others Institutions Holding IOVA

# of Institutions

313

Shares Held

237M

Call Options Held

3.77M

Put Options Held

1.7M

View Full List

About IOVANCE BIOTHERAPEUTICS, INC.

Ticker IOVA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 157,800,992
Market Cap $1.18B
Description
Iovance Biotherapeutics, Inc., a clinical-stage biotechnology company, focuses on developing and commercializing cancer immunotherapy products to harness the power of a patient's immune system to eradicate cancer cells. It has six ongoing phase 2 clinical studies, including C-144-01, of its lead product candidate, lifileucel, for the treatment o...

More about IOVA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Cutler Group LP, based on Form 13F filings with the SEC.

News

Stay updated on Cutler Group LP with notifications on news.

Account